Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 5/2012

01-07-2012 | Original Paper

Predictors of Linkage to Care Following Community-Based HIV Counseling and Testing in Rural Kenya

Authors: Abigail M. Hatcher, Janet M. Turan, Hannah H. Leslie, Lucy W. Kanya, Zachary Kwena, Malory O. Johnson, Starley B. Shade, Elizabeth A. Bukusi, Alexandre Doyen, Craig R. Cohen

Published in: AIDS and Behavior | Issue 5/2012

Login to get access

Abstract

Despite innovations in HIV counseling and testing (HCT), important gaps remain in understanding linkage to care. We followed a cohort diagnosed with HIV through a community-based HCT campaign that trained persons living with HIV/AIDS (PLHA) as navigators. Individual, interpersonal, and institutional predictors of linkage were assessed using survival analysis of self-reported time to enrollment. Of 483 persons consenting to follow-up, 305 (63.2%) enrolled in HIV care within 3 months. Proportions linking to care were similar across sexes, barring a sub-sample of men aged 18–25 years who were highly unlikely to enroll. Men were more likely to enroll if they had disclosed to their spouse, and women if they had disclosed to family. Women who anticipated violence or relationship breakup were less likely to link to care. Enrollment rates were significantly higher among participants receiving a PLHA visit, suggesting that a navigator approach may improve linkage from community-based HCT campaigns.
Literature
1.
Jahn A, Floyd S, Crampin AC, Mwaungulu F, Mvula H, Munthali F, et al. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet. 2008;10(371(9624)):1603–11.CrossRef
2.
Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;26(9635):293–9.
3.
Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med. 1998;26(338(13)):853–60.CrossRef
4.
Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;11(367(9513)):817–24.
5.
Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;1(22(15)):1897–908.CrossRef
6.
Krentz HB, Auld MC, Gill MJ. The high cost of medical care for patients who present late (CD4 < 200 cells/microL) with HIV infection. HIV Med. 2004;5(2):93–8.PubMedCrossRef
7.
Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Stein MD. Understanding delay to medical care for HIV infection: the long-term non-presenter. AIDS. 2001;5(15(1)):77–85.CrossRef
8.
Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86(7):559–67.PubMedCrossRef
9.
Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, Labatala V, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004;9(18(6)):887–95.CrossRef
10.
Toure S, Kouadio B, Seyler C, Traore M, Dakoury-Dogbo N, Duvignac J, et al. Rapid scaling-up of antiretroviral therapy in 10, 000 adults in Cote d’Ivoire: 2-year outcomes and determinants. AIDS. 2008;23(22(7)):873–82.CrossRef
11.
Fox MP, Sanne IM, Conradie F, Zeinecker J, Orrell C, Ive P, et al. Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microL is associated with improved treatment outcomes in South Africa. AIDS. 2010;24(24(13)):2041–50.PubMedCrossRef
12.
Stangl AL, Wamai N, Mermin J, Awor AC, Bunnell RE. Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda. AIDS Care. 2007;19(5):626–36.PubMedCrossRef
13.
Ford N, Kranzer K, Hilderbrand K, Jouquet G, Goemaere E, Vlahakis N, et al. Early initiation of antiretroviral therapy and associated reduction in mortality, morbidity and defaulting in a nurse-managed, community cohort in Lesotho. AIDS. 2010;24(17):2645.PubMedCrossRef
14.
Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;30(360(18)):1815–26.CrossRef
15.
Kigozi BK, Sumba S, Mudyope P, Namuddu B, Kalyango J, Karamagi C, et al. The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint. Clinical Research Centre, Uganda. AIDS Res Ther. 2009;6:17.
16.
Murphy RA, Sunpath H, Taha B, Kappagoda S, Maphasa KT, Kuritzkes DR, et al. Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis. 2010;14(7):903–8.PubMed
17.
Bunnell R, Mermin J, De Cock KM. HIV prevention for a threatened continent: implementing positive prevention in Africa. JAMA. 2006;16(296(7)):855–8.CrossRef
18.
Castilla J, Del Romero J, Hernando V, Marincovich B, Garcia S, Rodriguez C. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr. 2005;1(40(1)):96–101.
19.
Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr. 2007;46(1):S3–8.PubMedCrossRef
20.
Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;17(23(11)):1397–404.CrossRef
21.
Vernazza P, Hirschel B, Bernasconi E, Flepp M. HIV transmission under highly active antiretroviral therapy. Lancet. 2008;22(372(9652)):1806–7. author reply 1807.CrossRef
22.
Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48–57.PubMedCrossRef
23.
Menzies N, Abang B, Wanyenze R, Nuwaha F, Mugisha B, Coutinho A, et al. The costs and effectiveness of four HIV counseling and testing strategies in Uganda. AIDS. 2009;28(23(3)):395–401.CrossRef
24.
Negin J, Wariero J, Mutuo P, Jan S, Pronyk P. Feasibility, acceptability and cost of home-based HIV testing in rural Kenya. Trop Med Int Health. 2009;14(8):849–55.PubMedCrossRef
25.
Morin SF, Khumalo-Sakutukwa G, Charlebois ED, Routh J, Fritz K, Lane T, et al. Removing barriers to knowing HIV status: same-day mobile HIV testing in Zimbabwe. J Acquir Immune Defic Syndr. 2006;1(41(2)):218–24.
26.
Lugada E, Millar D, Haskew J, Grabowsky M, Garg N, Vestergaard M, et al. Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya. PLoS One. 2010;5(8):e12435.PubMedCrossRef
27.
Grabbe KL, Menzies N, Taegtmeyer M, Emukule G, Angala P, Mwega I, et al. Increasing access to HIV counseling and testing through mobile services in Kenya: strategies, utilization, and cost-effectiveness. J Acquir Immune Defic Syndr. 2010;1(54(3)):317–23.
28.
Tumwesigye E, Wana G, Kasasa S, Muganzi E, Nuwaha F. High uptake of home-based, district-wide, HIV counseling and testing in Uganda. AIDS Patient Care STDS. 2010;24(11):735–41.PubMedCrossRef
29.
Torian LV, Wiewel EW, Liu KL, Sackoff JE, Frieden TR. Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus. Arch Intern Med. 2008;9168(11):1181–7.CrossRef
30.
Mugavero M, Lin H, Allison J, Willig J, Chang P, Marler M, et al. Failure to establish HIV care: characterizing the “no show” phenomenon. Clin Infect Dis. 2007;45:127–30.PubMedCrossRef
31.
Reed JB, Hanson D, McNaghten AD, Bertolli J, Teshale E, Gardner L, et al. HIV testing factors associated with delayed entry into HIV medical care among HIV-infected persons from eighteen states, United States, 2000–2004. AIDS Patient Care STDS. 2009;23(9):765–73.PubMedCrossRef
32.
Ohl M, Tate J, Duggal M, Skanderson M, Scotch M, Kaboli P, et al. Rural residence is associated with delayed care entry and increased mortality among veterans with human immunodeficiency virus infection. Med Care. 2010;48(12):1064–70.PubMedCrossRef
33.
Tobias CR, Cunningham W, Cabral HD, Cunningham CO, Eldred L, Naar-King S, et al. Living with HIV but without medical care: barriers to engagement. AIDS Patient Care STDS. 2007;21(6):426–34.PubMedCrossRef
34.
Decroo T, Panunzi I, das Dores C, Maldonado F, Biot M, Ford N, et al. Lessons learned during down referral of antiretroviral treatment in Tete, Mozambique. J Int AIDS Soc. 2009;12(1):6.PubMedCrossRef
35.
Bassett IV, Regan S, Chetty S, Giddy J, Uhler LM, Holst H, et al. Who starts antiretroviral therapy in Durban, South Africa? not everyone who should. AIDS. 2010;24(Suppl 1):S37–44.PubMedCrossRef
36.
Unge C, Johansson A, Zachariah R, Some D, Van Engelgem I, Ekstrom AM. Reasons for unsatisfactory acceptance of antiretroviral treatment in the urban Kibera slum, Kenya. AIDS Care. 2008;20(2):146–9.PubMedCrossRef
37.
Wanyenze RK, Hahn JA, Liechty CA, Ragland K, Ronald A, Mayanja-Kizza H, et al. Linkage to HIV Care and survival following inpatient HIV counseling and testing. AIDS Behav. 2011;15(4):751–60.PubMedCrossRef
38.
Kranzer K, Zeinecker J, Ginsberg P, Orrell C, Kalawe NN, Lawn SD, et al. Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS One. 2010;5(11):e13801.PubMedCrossRef
39.
Nakigozi G, Makumbi F, Reynolds S, Galiwango R, Kagaayi J, Nalugoda F, et al. Non-enrollment for free community HIV care: findings from a population-based study in Rakai, Uganda. AIDS Care. 2011;23(6):764–70.PubMedCrossRef
40.
Rosen S, Fox MP. Retention in HIV Care between testing and treatment in Sub-Saharan Africa: a systematic review. PLoS Med. 2011;8(7):e1001056.PubMedCrossRef
41.
Sweat M, Morin S, Celentano D, Mulawa M, Singh B, Mbwambo J, et al. Community-based intervention to increase HIV testing and case detection in people aged 16–32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infect Dis. 2011;11(7):525–32. 3.PubMedCrossRef
42.
Braitstein P, Boulle A, Nash D, Brinkhof MW, Dabis F, Laurent C, et al. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health. 2008;17(1):47–55.CrossRef
43.
Amuyunzu-Nyamongo M, Okeng’o L, Wagura A, Mwenzwa E. Putting on a brave face: the experiences of women living with HIV and AIDS in informal settlements of Nairobi, Kenya. AIDS Care. 2007;19:S25–34.PubMedCrossRef
44.
Bond V. Stigma when there is no other option: understanding how poverty fuels discrimination toward people living with HIV in Zambia. AIDS, Poverty, and Hunger. Washington: International Food Policy Research Insitute; 2006. p. 181–197.
45.
Kiwanuka SN, Ekirapa EK, Peterson S, Okui O, Rahman MH, Peters D, et al. Access to and utilisation of health services for the poor in Uganda: a systematic review of available evidence. Trans R Soc Trop Med Hyg. 2008;102(11):1067–74.PubMedCrossRef
46.
Mshana GH, Wamoyi J, Busza J, Zaba B, Changalucha J, Kaluvya S, et al. Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS. 2006;20(9):649–57.PubMedCrossRef
47.
Murray LK, Semrau K, McCurley E, Thea DM, Scott N, Mwiya M, et al. Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care. 2009;21(1):78–86.PubMedCrossRef
48.
Otieno PA, Kohler PK, Bosire RK, Brown ER, Macharia SW, John-Stewart GC. Determinants of failure to access care in mothers referred to HIV treatment programs in Nairobi, Kenya. AIDS Care. 2010;22(6):729–36.PubMedCrossRef
49.
Posse M, Meheus F, van Asten H, van der Ven A, Baltussen R. Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Health. 2008;13(7):904–13.PubMedCrossRef
50.
Marum E, Taegtmeyer M, Chebet K. Scale-up of voluntary HIV counseling and testing in Kenya. JAMA. 2006;16(296(7)):859–62.CrossRef
51.
Mugavero MJ, Norton W, Saag. Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragmanets of a fractured health care delivery system. Clin Infect Dis. 2011;52((S2)):S238–46.PubMedCrossRef
52.
DiClemente RJ, Salazar LF, Crosby RA. A review of STD/HIV preventive interventions for adolescents: sustaining effects using an ecological approach. J Pediatr Psychol. 2007;32(8):888–906.PubMedCrossRef
53.
Latkin CA, Knowlton AR. Micro-social structural approaches to HIV prevention: a social ecological perspective. AIDS Care. 2005;17(1):S102–13.PubMedCrossRef
54.
McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item short-form health survey (SF-36) II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31(3):247–63.PubMedCrossRef
55.
Monahan PO, Shacham E, Reece M, Kroenke K, Ong’or WO, Omollo O, et al. Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in Western Kenya. J Gen Intern Med. 2009;24(2):189–97.PubMedCrossRef
56.
Harrison A, O’Sullivan LF, Hoffman S, Dolezal C, Morrell R. Gender role and relationship norms among young adults in South Africa: measuring the context of masculinity and HIV risk. J Urban Health. 2006;83(4):709–22.PubMedCrossRef
57.
Turan JM, Bukusi EA, Onono M, Holzemer WL, Miller S, Cohen CR. HIV/AIDS stigma and refusal of HIV testing among pregnant women in rural Kenya: results from the MAMAS Study. AIDS Behav. 2011;15(6):1111–20.PubMedCrossRef
58.
Weiser S, Heisler M, Leiter K, Percy-de Korte F, Tlou S, DeMonner S. Routine HIV testing in Botswana: a population based study on attitudes, practices, and human rights concerns. PLoS Med. 2006;3:e261.PubMedCrossRef
59.
Genberg BL, Kawichai S, Chingono A, Sendah M, Chariyalertsak S, Konda KA, et al. Assessing HIV/AIDS stigma and discrimination in developing countries. AIDS Behav. 2008;12(5):772–80.PubMedCrossRef
60.
Holzemer WL, Uys L, Makoae L, Stewart A, Phetlhu R, Dlamini PS, et al. A conceptual model of HIV/AIDS stigma from five African countries. J Adv Nurs. 2007;58(6):541–51.PubMedCrossRef
61.
Gielen AC, McDonnell KA, Wu AW, O’Campo P, Faden R. Quality of life among women living with HIV: the importance violence, social support, and self care behaviors. Soc Sci Med. 2001;52(2):315–22.PubMedCrossRef
62.
Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658–65.PubMedCrossRef
63.
Cohen CR, Montandon M, Carrico AW, Shiboski S, Bostrom A, Obure A, et al. Association of attitudes and beliefs towards antiretroviral therapy with HIV-seroprevalence in the general population of Kisumu, Kenya. PLoS One. 2009;4(3):e4573.PubMedCrossRef
64.
Nsigaye R, Wringe A, Roura M, Kalluvya S, Urassa M, Busza J, et al. From HIV diagnosis to treatment: evaluation of a referral system to promote and monitor access to antiretroviral therapy in rural Tanzania. J Int AIDS Soc. 2009;12(1):31.PubMedCrossRef
65.
Anyango B. personal communication. Kisumu: Tuungane Health Center; 2009.
66.
Menya P. Personal communication. Kisumu: Liverpool VCT; 2009.
67.
Musili P. Personal communication. Eldoret: AMPATH; 2009.
68.
Adeneye AK, Adewole TA, Musa AZ, Onwujekwe D, Odunukwe NN, Araoyinbo ID, et al. Limitations to access and use of antiretroviral therapy (ART) among HIV positive persons in Lagos, Nigeria. World Health Popul. 2006;8(2):46–56.PubMed
69.
Nyanzi-Wakholi B, Lara AM, Watera C, Munderi P, Gilks C, Grosskurth H. The role of HIV testing, counselling, and treatment in coping with HIV/AIDS in Uganda: a qualitative analysis. AIDS Care. 2009;21(7):903–8.PubMedCrossRef
70.
Lertpiriyasuwat C, Yachompoo C, Yuktanon P, Thanprasertsuk S, Leusaree T, Khemngern P, et al., editors. Access to antiretroviral drugs in northern Thailand: perspectives of persons living with HIV/AIDS. Bangkok: XV International AIDS Conference; 2004.
71.
Efuntoye M, Okonkwo O, Omorgeie G, Musa G. Increasing access to HIV counselling and testing: a demonstration project trialling the greater involvement of people living with HIV/AIDS (GIPA) in the workplace.” Abstract TUZX0405. Mexico: XVII International AIDS Conference; 2008.
72.
Chang LW, Kagaayi J, Nakigozi G, Ssempijja V, Packer AH, Serwadda D, et al. Effect of peer health workers on AIDS care in Rakai, Uganda: a cluster-randomized trial. PLoS One. 2010;5(6):e10923.PubMedCrossRef
73.
Mukherjee J, Leandre F, Lambert W, editors. Excellent outcomes, high retention in treatment, and low rate of switch to second line ART in community based HIV treatment program in Haiti. Mexico: XVII International AIDS conference Mexico; 2008.
74.
Kabore I, Bloem J, Etheredge G, Obiero W, Wanless S, Doykos P, et al. The effect of community-based support services on clinical efficacy and health-related quality of life in HIV/AIDS patients in resource-limited settings in sub-Saharan Africa. AIDS Patient Care STDS. 2010;24(9):581–94.PubMedCrossRef
75.
Cabral HJ, Tobias C, Rajabiun S, Sohler N, Cunningham C, Wong M, et al. Outreach program contacts: do they increase the likelihood of engagement and retention in HIV primary care for hard-to-reach patients? AIDS Patient Care STDS. 2007;21(1):S59–67.PubMedCrossRef
76.
Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, del Rio C, Strathdee S, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;4(19(4)):423–31.CrossRef
77.
Bradford JB, Coleman S, Cunningham W. HIV system navigation: an emerging model to improve HIV care access. AIDS Patient Care STDS. 2007;21(1):S49–58.PubMed
78.
Louis C, Ivers LC, Smith Fawzi MC, Freedberg KA, Castro A. Late presentation for HIV care in central Haiti: factors limiting access to care. AIDS Care. 2007;19(4):487–91.PubMedCrossRef
79.
Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009;1(52(2)):280–9.
80.
Fonck K, Mwai C, Ndinya-Achola J, Bwayo J, Temmerman M. Health-seeking and sexual behaviors among primary healthcare patients in Nairobi, Kenya. Sex Transm Dis. 2002;29(2):106–11.PubMedCrossRef
81.
Taegtmeyer M, Kilonzo N, Mung’ala L, Morgan G, Theobald S. Using gender analysis to build voluntary counselling and testing responses in Kenya. Trans R Soc Trop Med Hyg. 2006;100(4):305–11.PubMedCrossRef
82.
Voeten HA, O’Hara HB, Kusimba J, Otido JM, Ndinya-Achola JO, Bwayo JJ, et al. Gender differences in health care-seeking behavior for sexually transmitted diseases: a population-based study in Nairobi, Kenya. Sex Transm Dis. 2004;31(5):265–72.PubMedCrossRef
83.
Luseno WK, Wechsberg WM, Kline TL, Ellerson RM. Health services utilization among South African women living with HIV and reporting sexual and substance-use risk behaviors. AIDS Patient Care STDS. 2010;24(4):257–64.PubMedCrossRef
84.
Boyer S, Marcellin F, Ongolo-Zogo P, Abega SC, Nantchouang R, Spire B, et al. Financial barriers to HIV treatment in Yaounde, Cameroon: first results of a national cross-sectional survey. Bull World Health Organ. 2009;87(4):279–87.PubMedCrossRef
85.
Karcher H, Omondi A, Odera J, Kunz A, Harms G. Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health. 2007;12(5):687–94.PubMedCrossRef
86.
Smith R, Carrico A, Montadon M, Bailey R, Kwena Z, Bukusi E, et al. Attitudes and beliefs about antiretroviral therapy are associated with risky sexual behavior in Kisumu, Kenya. 6th annual Conference on Retroviruses and Opportunistic Infectional. Montreal: 2009;Feb. 8–10.
87.
Unge C, Johansson A, Zachariah R, Some D, Van Engelgem I, Ekstrom AM. Reasons for unsatisfactory acceptance of antiretroviral treatment in the urban Kibera slum, Kenya. AIDS Care. 2008;20(2):146–9.PubMedCrossRef
88.
Stevens W, Kaye S, Corrah T. Antiretroviral therapy in Africa. BMJ. 2004;31(328(7434)):280–2.CrossRef
89.
Micek MA, Gimbel-Sherr K, Baptista AJ, Matediana E, Montoya P, Pfeiffer J, et al. Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr. 2009;1(52(3)):397–405.
90.
Olley BO, Seedat S, Stein DJ. Self-disclosure of HIV serostatus in recently diagnosed patients with HIV in South Africa. Afr J Reprod Health. 2004;8(2):71–6.PubMedCrossRef
91.
Maman S, Mbwambo J, Hogan NM, Kilonzo GP, Sweat M. Women’s barriers to HIV-1 testing and disclosure: challenges for HIV-1 voluntary counselling and testing. AIDS Care. 2001;13(5):595–603.PubMedCrossRef
92.
Emusu D, Ivankova N, Jolly P, Kirby R, Foushee H, Wabwire-Mangen F, et al. Experience of sexual violence among women in HIV discordant unions after voluntary HIV counselling and testing: a qualitative critical incident study in Uganda. AIDS Care. 2009;21(11):1363–70.PubMedCrossRef
93.
Mlay R, Lugina H, Becker S. Couple counselling and testing for HIV at antenatal clinics: views from men, women and counsellors. AIDS Care. 2008;20(3):356–60.PubMedCrossRef
94.
Martin-Herz SP, Shetty AK, Bassett MT, Ley C, Mhazo M, Moyo S, et al. Perceived risks and benefits of HIV testing, and predictors of acceptance of HIV counselling and testing among pregnant women in Zimbabwe. Int J STD AIDS. 2006;17(12):835–41.PubMedCrossRef
95.
Pool R, Nyanzi S, Whitworth JA. Attitudes to voluntary counselling and testing for HIV among pregnant women in rural south-west Uganda. AIDS Care. 2001;13(5):605–15.PubMedCrossRef
96.
Gielen AC, McDonnell KA, Burke JG, O’Campo P. Women’s lives after an HIV-positive diagnosis: disclosure and violence. Matern Child Health J. 2000;4(2):111–20.PubMedCrossRef
97.
Grinstead OA, Gregorich SE, Choi KH, Coates T. Positive and negative life events after counselling and testing: the Voluntary HIV-1 counselling and testing efficacy study. AIDS. 2001;25(15(8)):1045–52.CrossRef
98.
Kilewo C, Massawe A, Lyamuya E, Semali I, Kalokola F, Urassa E, et al. HIV counseling and testing of pregnant women in sub-Saharan Africa: experiences from a study on prevention of mother-to-child HIV-1 transmission in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 2001;15(28(5)):458–62.
99.
Maman S, Mbwambo JK, Hogan NM, Kilonzo GP, Campbell JC, Weiss E, et al. HIV-positive women report more lifetime partner violence: findings from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania. Am J Public Health. 2002;92(8):1331–7.PubMedCrossRef
100.
Makoae LN, Greeff M, Phetlhu RD, Uys LR, Naidoo JR, Kohi TW, et al. Coping with HIV-related stigma in five African countries. J Assoc Nurses AIDS Care. 2008;19(2):137–46.PubMedCrossRef
101.
Nam SL, Fielding K, Avalos A, Dickinson D, Gaolathe T, Geissler PW. The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med. 2008;67(2):301–10.PubMedCrossRef
102.
Ogden J, Nyblade L. Common at its core: HIV-related stigma across contexts. Washington: International Center for Research on Women. 2005.
103.
Reis C, Heisler M, Amowitz L. Discriminatory attitudes and practices by health workers toward patients with HIV/AIDS in Nigeria. PLoS Med. 2005;2(8):e246.PubMedCrossRef
104.
Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in Southwestern Uganda: a qualitative study. AIDS Behav. 2009;14(4):778–84. 13.PubMedCrossRef
105.
Assefa Y, Van Damme W, Mariam DH, Kloos H. Toward universal access to HIV counseling and testing and antiretroviral treatment in Ethiopia: looking beyond HIV testing and ART initiation. AIDS Patient Care STDS. 2010;24(8):521–5.PubMedCrossRef
106.
Larson BA, Brennan A, McNamara L, Long L, Rosen S, Sanne I, et al. Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health. 2010;15(1):43–7.PubMedCrossRef
107.
Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grosskurth H, et al. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009;9:290.
108.
Hoffman RM, Black V, Technau K, van der Merwe KJ, Currier J, Coovadia A, et al. Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2010;1(54(1)):35–41.
109.
WHO. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Geneva: World Health Organization. 2008.
110.
Kairania R, Gray RH, Kiwanuka N, Makumbi F, Sewankambo NK, Serwadda D, et al. Disclosure of HIV results among discordant couples in Rakai, Uganda: a facilitated couple counselling approach. AIDS Care. 2010;22(9):1041–51.PubMedCrossRef
111.
Farquhar C, Kiarie JN, Richardson BA, Kabura MN, John FN, Nduati RW, et al. Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission. J Acquir Immune Defic Syndr. 2004;15(375):1620–6.
Metadata
Title
Predictors of Linkage to Care Following Community-Based HIV Counseling and Testing in Rural Kenya
Authors
Abigail M. Hatcher
Janet M. Turan
Hannah H. Leslie
Lucy W. Kanya
Zachary Kwena
Malory O. Johnson
Starley B. Shade
Elizabeth A. Bukusi
Alexandre Doyen
Craig R. Cohen
Publication date
01-07-2012
Publisher
Springer US
Published in
AIDS and Behavior / Issue 5/2012
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-0065-1

Other articles of this Issue 5/2012

AIDS and Behavior 5/2012 Go to the issue

Original Paper

How Treatment Partners Help: Social Analysis of an African Adherence Support Intervention

Original Paper

Predicting Partner HIV Testing and Counseling Following a Partner Notification Intervention

Original Paper

A Randomized Controlled Trial to Evaluate the Relative Efficacy of Enhanced Versus Standard Voluntary Counseling and Testing on Promoting Condom Use among Men Who Have Sex with Men in China

Original Paper

Cognitive Behavioral HIV Risk Reduction in Those Receiving Psychiatric Treatment: A Clinical Trial

Original Paper

NIMH Project Accept (HPTN 043) HIV/AIDS Community Mobilization (CM) to Promote Mobile HIV Voluntary Counseling and Testing (MVCT) in Rural Communities in Northern Thailand: Modifications by Experience

Original Paper

The Impact of Prolonged Exposure on PTSD Symptoms and Associated Psychopathology in People Living with HIV: A Randomized Test of Concept
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits